This year, more than 46,000 people in the United States will be diagnosed with pancreatic cancer, according to the American Cancer Society. November is Pancreatic Cancer Awareness Month, and many people are doing their part to bring attention to this devastating disease.
Pancreatic cancer has a very high mortality rate, partly because it manifests itself with subtle symptoms, such as loss of appetite and heartburn. Diagnosis and treatment can be physically and emotionally traumatic, but recent advances are promising.
Charles J. Yeo, MD, FACS, Chair of the Department of Surgery and Co-Director of the Pancreas, Biliary and Related Cancer Center recently spoke with CBS 3 about treatment for this life-threatening disease.
“We have a lot of excitement in the field. We have guarded enthusiasm in the field.” said Dr. Yeo.
Jefferson is a leader in bench-to-bedside research leading to better treatments—and new surgical techniques that improve survival rates.
But more research and advocacy are needed, and that’s where the Pancreatic Cancer Action Network’s Purple Stride Philadelphia steps in.
On November 1, Dr. Yeo participated in this annual walk to support pancreatic cancer research, held in Fairmount Park. Dr. Yeo was honorary chair of the event, and 23 members of Jefferson’s Gibbon Surgical Society were on hand to raise money and awareness for pancreatic cancer. Jefferson’s team surpassed its fundraising goal to advance research, support patients, and create hope.